Market Research Logo

Analysis of the US Autoimmune Disease Diagnostics Market

Analysis of the US Autoimmune Disease Diagnostics Market

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.


  • Methodology
  • Executive Summary
    • Scope and Segmentation
    • Key Predictions: US Autoimmune Disease Diagnostics Market
    • Current Trends in the Autoimmune Disease Diagnostics Market
    • Autoimmune Disease Diagnostics Market-Overview
    • Key Companies to Watch
  • Competitive Overview
    • Ecosystem of the Autoimmune Disease Diagnostics Market
    • Significance of the Autoimmune Disease Diagnostics Market
    • Significance of the Autoimmune Disease Diagnostics Market-Prevalence Rates
    • Competitive Landscape
    • Key Diseases and Available Solutions in the US Market
    • LDTs-Role in Autoimmune Disease Diagnostics
    • Segment Lifecycle Analysis by Disease
    • Overall Market Forecast
    • Overall Disease Segment Share
    • Competitive SWOT Analysis by Company
  • Growth Opportunities
    • Where do the Opportunities Lie in this Market?
    • Pharma and Diagnostics Business Integration
    • Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
    • Direct-to-Consumer Market: The Risk and The Opportunity
  • Localized Disease Diagnostics Segment
    • Localized Disease Diagnostics Segment Revenue
      • Table Localized Disease Diagnostics Segment: Revenue Forecast, US, 2011-2020
    • Growth Rate by Localized Autoimmune Diseases
      • Table Localized Disease Diagnostics Segment: Growth Rate by Disease Type, US, 2012-2020
      • Table Localized Disease Diagnostics Segment: Average Price by Disease Type, US, 2011-2020
    • Competitive Value Matrix-Localized Disease Diagnostics Segment
    • Autoimmune Tests-Role in Patient Continuum
  • Systemic Disease Diagnostics Segment
    • Systemic Disease Diagnostics Segment Revenue
      • Table Systemic Disease Diagnostics Segment: Revenue Forecast, US, 2011-2020
    • Growth Rate by Systemic Autoimmune Diseases
      • Table Systemic Disease Diagnostics Segment: Growth Rate by Disease Type, US, 2012-2020
      • Table Systemic Disease Diagnostics Segment: Average Price by Disease Type, US, 2011-2020
    • Competitive Value Matrix-Systemic Disease Diagnostics Segment
    • Autoimmune Tests-Role in Patient Continuum
  • Conclusion
    • Key Conclusions and Future Outlook
  • Appendix-List of LDTs
    • Celiac Disease-specific LDT Assays
    • Chron's Disease-specific LDT Assays
    • RA-specific LDT Assays
    • Lupus-specific LDT Assays
    • IBD/IBS-specific LDT Assays
    • Others

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report